MAXIMUM OTC STRENGTH FEMININE ANTI-ITCH CREME- benzocaine, resorcinol cream

Maximum OTC Strength Feminine Anti-Itch Creme by

Drug Labeling and Warnings

Maximum OTC Strength Feminine Anti-Itch Creme by is a Otc medication manufactured, distributed, or labeled by Quality Choice (CHAIN DRUG MARKETING ASSOCIATION). Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts Active ingredients

Benzocaine 20%

Resorcinol 3%

Purpose

External analgesic

Keep out of reach of children

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Use

temporarily relieves itching

Warnings

For external use only

When using this product

avoid contact with the eyes

Stop use and ask a doctor if

condition worsens, or if symptoms persist for more than7 days or clear up and occur again within a few days

Do not apply Directions

Do not apply over large area of the body.

adults and children 12 years and older: apply a fingertip amount (approximately 1-inch strip) to the affected area not more than 3 to 4 times daily

children under 12 years: do not use; consult a doctor

Other Information

store at 20° -25° C (68° -77° F)

Inactive Ingredients

aloe vera leaf, alpha-tocopherol, butylated hydroxytoluene, carbomer, cetyl alcohol cholecalciferol, glyceryl monostearate,

isopropyl myristate, isopropyl palmitate, isopropyl stearate, mineral oil, PEG 100 stearate, PEG 4000, phenoxy ethanol, propylene glycol, sodium hydroxide, sodium lauryl sulfate, trisodium edta, vitamin A palmitate, water

Questions or comments?

1-866-326-1313

Quality Choice Maximum OTC Strength Feminine Anti-itch Creme

INGREDIENTS AND APPEARANCE

MAXIMUM OTC STRENGTH FEMININE ANTI-ITCH CREME 
benzocaine, resorcinol cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 83324-019
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5)	BENZOCAINE	5.67 g  in 28 g
RESORCINOL (UNII: YUL4LO94HK) (RESORCINOL - UNII:YUL4LO94HK)	RESORCINOL	0.85 g  in 28 g

Inactive Ingredients
Ingredient Name	Strength
CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 4Q93RCW27E)
CETYL ALCOHOL (UNII: 936JST6JCN)
CHOLECALCIFEROL (UNII: 1C6V77QF41)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
ISOPROPYL MYRISTATE (UNII: 0RE8K4LNJS)
ISOPROPYL PALMITATE (UNII: 8CRQ2TH63M)
ISOPROPYL STEARATE (UNII: 43253ZW1MZ)
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
POLYETHYLENE GLYCOL 4000 (UNII: 4R4HFI6D95)
MINERAL OIL (UNII: T5L8T28FGP)
PEG-100 STEARATE (UNII: YD01N1999R)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
WATER (UNII: 059QF0KO0R)
ALOE VERA LEAF (UNII: ZY81Z83H0X)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
ALPHA-TOCOPHEROL (UNII: H4N855PNZ1)
EDETATE TRISODIUM (UNII: 420IP921MB)
PHENOXYETHANOL (UNII: HIE492ZZ3T)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 83324-019-01	28.3 g in 1 TUBE; Type 0: Not a Combination Product	01/01/2024

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M017	01/01/2024

Labeler - Quality Choice (CHAIN DRUG MARKETING ASSOCIATION) (011920774)